# FDA Inspection 1245029 - Chongqing Daxin Pharmaceutical Co., Ltd. - June 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/9d9c682d-2383-480f-8b01-ae1b51e3e370
Source feed: FDA_Inspections

> FDA Inspection 1245029 for Chongqing Daxin Pharmaceutical Co., Ltd. on June 28, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245029
- Company Name: Chongqing Daxin Pharmaceutical Co., Ltd.
- Inspection Date: 2024-06-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1056109 - 2018-05-11](https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/cda74d6b-05ac-44c9-a971-2273e84327b9)
- [FDA Inspection 912081 - 2015-01-29](https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/978947b5-3c24-4523-8c63-4ce4f89716b1)

Company: https://www.keypedia.com/companies/chongqing-daxin-pharmaceutical-co-ltd/41f80e0d-c994-41e7-aa3f-32c2aabcea04

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c